Fulgent Genetics (NASDAQ:FLGT – Get Free Report) updated its FY 2024 earnings guidance on Wednesday. The company provided EPS guidance of -1.050–1.050 for the period, compared to the consensus EPS estimate of -0.950. The company issued revenue guidance of $280.0 million-$280.0 million, compared to the consensus revenue estimate of $294.2 million. Fulgent Genetics also updated […]